Genetic testing, also known as DNA testing, allows the determination of bloodlines and the genetic diagnosis of vulnerabilities to inherited diseases. In agriculture, a form of genetic testing known as progeny testing can be used to evaluate the quality of breeding stock. In population ecology, genetic testing can be used to track genetic strengths and vulnerabilities of species populations.
The demand for genetic testing is growing owing to the increasing genetic mutations in fetuses and newborns and growing prevalence of hereditary genetic disorders, and infectious diseases. In the US, a large number of infants are being born with congenital heart disease (CHD). Owing to factors such as genetic conditions, the consumption of medications or alcohol during pregnancy, or viral infection, infants are susceptible to developing CHD. Technavio’s market study identifies the growing prevalence of genetic disorders to be one of the primary growth factors for the genetic testing market. CHD may occur in infants in varying patterns such as autosomal dominant, autosomal recessive, X-linked dominant, and X-linked recessive. A key vendor manufactured Invitae Congenital Heart Disease Panel, that can analyze efficiently 42 genes that cause CHD prematurely.

Market Analysis and Insights: Global Genetic Testing Market
The global Genetic Testing market size is projected to reach US$ 12860 million by 2027, from US$ 6841.1 million in 2020, at a CAGR of 9.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genetic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genetic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genetic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genetic Testing market.

Global Genetic Testing Scope and Market Size
Genetic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Analyzers
Consumables

Segment by Application
Predictive and Diagnostic Testing
Prenatal, Newborn, and Pre-Implantation Testing
Pharmacogenomic Testing
Forensic, Relationship, and Ancestry Testing

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
bioMérieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Myriad Genetics
QIAGEN
Quest Diagnostics